CTNM

NASDAQ:CTNM

Contineum Therapeutics

  • Stock

USD

Last Close

11.01

06/11 21:00

Market Cap

541.73M

Beta: -

Volume Today

132.52K

Avg: -

PE Ratio

−20.64

PFCF: −17.65

OverviewFinancialsAPI
Income StatementBalance SheetCash FlowKey MetricsRatios
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '21
Dec '22
asset turnover
cash per share
4.14
-
1.88
54.58%
company equity multiplier
-0.99
-
-0.54
45.39%
days of inventory outstanding
days of payables outstanding
477.05
-
days of sales outstanding
dividend yield
ebit per revenue
ebt per ebit
1.01
-
1.07
5.44%
effective tax rate
-0.01
-
enterprise value multiple
-9.07
-
-23.21
155.89%
fixed asset turnover
free cash flow per share
-1.59
-
-0.81
49.20%
gross profit margin
interest coverage
-86.29
-
-58.56
32.14%
inventory turnover
long term debt to capitalization
-0.05
-
3.37
6,299.10%
net income per ebt
1
-
1
0%
net profit margin
operating cash flow per share
-1.58
-
-0.80
49.17%
operating profit margin
payables turnover
0.77
-
pretax profit margin
price fair value
-3.62
-
-4.15
14.63%
receivables turnover
return on assets
-0.41
-
-0.48
16.46%
return on capital employed
-0.43
-
-0.53
23.04%
return on equity
0.41
-
0.26
36.40%
total debt to capitalization
-0.07
-
3.10
4,270.64%

All numbers in USD (except ratios and percentages)